215 related articles for article (PubMed ID: 30259122)
1. Cellular and sub-cellular localisation of oxyntomodulin-like immunoreactivity in enteroendocrine cells of human, mouse, pig and rat.
Fothergill LJ; Ringuet MT; Sioras E; Hunne B; Fazio Coles TE; Martins PR; Furness JB
Cell Tissue Res; 2019 Feb; 375(2):359-369. PubMed ID: 30259122
[TBL] [Abstract][Full Text] [Related]
2. Differences in hormone localisation patterns of K and L type enteroendocrine cells in the mouse and pig small intestine and colon.
Cho HJ; Kosari S; Hunne B; Callaghan B; Rivera LR; Bravo DM; Furness JB
Cell Tissue Res; 2015 Feb; 359(2):693-698. PubMed ID: 25378285
[TBL] [Abstract][Full Text] [Related]
3. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
Kervran A; Blache P; Bataille D
Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
[TBL] [Abstract][Full Text] [Related]
4. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
5. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
Blache P; Kervran A; Bataille D
Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
[TBL] [Abstract][Full Text] [Related]
6. A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties.
Bhat VK; Kerr BD; Flatt PR; Gault VA
Biochem Pharmacol; 2013 Jun; 85(11):1655-62. PubMed ID: 23518155
[TBL] [Abstract][Full Text] [Related]
7. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
Blache P; Kervran A; Martinez J; Bataille D
Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
[TBL] [Abstract][Full Text] [Related]
8. The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs.
Wewer Albrechtsen NJ; Kuhre RE; Toräng S; Holst JJ
BMC Res Notes; 2016 Feb; 9():60. PubMed ID: 26830025
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 1 and peptide YY are in separate storage organelles in enteroendocrine cells.
Cho HJ; Robinson ES; Rivera LR; McMillan PJ; Testro A; Nikfarjam M; Bravo DM; Furness JB
Cell Tissue Res; 2014 Jul; 357(1):63-9. PubMed ID: 24842049
[TBL] [Abstract][Full Text] [Related]
10. Distribution and characterisation of CCK containing enteroendocrine cells of the mouse small and large intestine.
Fakhry J; Wang J; Martins P; Fothergill LJ; Hunne B; Prieur P; Shulkes A; Rehfeld JF; Callaghan B; Furness JB
Cell Tissue Res; 2017 Aug; 369(2):245-253. PubMed ID: 28413860
[TBL] [Abstract][Full Text] [Related]
11. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
Maida A; Lovshin JA; Baggio LL; Drucker DJ
Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
[TBL] [Abstract][Full Text] [Related]
12. Novel glucagon- and OXM-based peptides acting through glucagon and GLP-1 receptors with body weight reduction and anti-diabetic properties.
Cai X; Li C; Zhou J; Dai Y; Avraham Y; Sun L; Liu C; Tong J; Wang Y; Bi X; He L; Huang W; Qian H
Bioorg Chem; 2020 Jan; 95():103538. PubMed ID: 31901754
[TBL] [Abstract][Full Text] [Related]
13. Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine.
Pellissier S; Sasaki K; Le-Nguyen D; Bataille D; Jarrousse C
Neurogastroenterol Motil; 2004 Aug; 16(4):455-63. PubMed ID: 15306001
[TBL] [Abstract][Full Text] [Related]
14. Oxyntomodulin reduces hydromineral transport through rat small intestine.
Beauclair F; Eto B; Pansu D; Rodier G; Mochizuki T; Martinez J; Bataille D; Jarrousse C
Dig Dis Sci; 1998 Aug; 43(8):1814-23. PubMed ID: 9724174
[TBL] [Abstract][Full Text] [Related]
15. Comparison of stability, cellular, glucose-lowering and appetite supressing effects of oxyntomodulin analogues modified at the N-terminus.
Lynch AM; Pathak N; Flatt YE; Gault VA; O'Harte FP; Irwin N; Flatt PR
Eur J Pharmacol; 2014 Nov; 743():69-78. PubMed ID: 25246014
[TBL] [Abstract][Full Text] [Related]
16. Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats.
Anini Y; Jarrousse C; Chariot J; Nagain C; Yanaihara N; Sasaki K; Bernad N; Le Nguyen D; Bataille D; Rozé C
Pancreas; 2000 May; 20(4):348-60. PubMed ID: 10824688
[TBL] [Abstract][Full Text] [Related]
17. Oxyntomodulin analog and exendin-4 derivative lower plasma glucose in cattle.
ThanThan S; Asada Y; Saito T; Ochiiwa K; Zhao H; Naing SW; Kuwayama H
Domest Anim Endocrinol; 2017 Apr; 59():30-36. PubMed ID: 27888738
[TBL] [Abstract][Full Text] [Related]
18. Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cells.
Rodier G; Magous R; Mochizuki T; Martinez J; Nguyen DL; Bali JP; Bataille D; Jarrousse C
Pflugers Arch; 1997 Nov; 434(6):729-34. PubMed ID: 9306005
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.
Eissele R; Göke R; Willemer S; Harthus HP; Vermeer H; Arnold R; Göke B
Eur J Clin Invest; 1992 Apr; 22(4):283-91. PubMed ID: 1499644
[TBL] [Abstract][Full Text] [Related]
20. Degradation and Stabilization of Peptide Hormones in Human Blood Specimens.
Yi J; Warunek D; Craft D
PLoS One; 2015; 10(7):e0134427. PubMed ID: 26222180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
